Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S5W-35154 · Session 5

What the process is for the utilisation of left over COVID-19 vaccines.

Answered Asked by Pauline McNeill Lab Lodged 10 Feb 2021

The question

To ask the Scottish Government what the process is for the utilisation of left over COVID-19 vaccines.

The answer

Answered by Mairi Gougeon on 2 Mar 2021 · 20 days after it was lodged, 5 days after it was due

We have been clear we expect health boards to minimise wasted doses of vaccine, and have provided them with best practice advice on how to achieve this.
Some wastage is unavoidable for a variety of reasons based on the characteristics of the vaccine, logistical issues with cold chain supply, storage failure and/or specific clinical situations such as a breakout of COVID-19 in a care home. To date, our latest management information indicates a wastage rate of around only 1.8%
- well below our planning assumption of 5%, which is a precautionary approach for worst case scenarios and in line with global best practice.
Any wastage is reviewed to ensure any preventable loss is avoided in the future. We will continue to monitor wastage rates and regularly report back.
A waste management tool is now in place to learn why waste is arising so that solutions can be put in place to minimise waste. It will also provide the ability to extract data on the number of doses not able to be used for various reasons. On the 9 February, NHS Lothian shared online the opportunity for staff who had not yet received a first or second dose of the Pfizer vaccine to attend as the adverse weather meant appointments were available at short notice. We are pleased to see Boards acting pragmatically to ensure we adhere to the JCVI priority list whilst continuing to minimise vaccine waste.

In the Official Report

No contribution in the Official Report cites S5W-35154 by reference.